186 related articles for article (PubMed ID: 36473315)
1. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer.
Xu X; Li Y; Wu Y; Wang M; Lu Y; Fang Z; Wang H; Li Y
Redox Biol; 2023 Feb; 59():102564. PubMed ID: 36473315
[TBL] [Abstract][Full Text] [Related]
2. Amentoflavone attenuates cell proliferation and induces ferroptosis in human gastric cancer by miR-496/ATF2 axis.
Tang F; Xu Y; Gao E; Zhang W; Zhang F; Xiang Y; Xu L; Dong F
Chem Biol Drug Des; 2023 Oct; 102(4):782-792. PubMed ID: 37455326
[TBL] [Abstract][Full Text] [Related]
3. ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis.
Wang L; Chen Y; Mi Y; Qiao J; Jin H; Li J; Lu Z; Wang Q; Zou Z
Biochem Biophys Res Commun; 2021 Jun; 558():216-223. PubMed ID: 33008584
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway.
Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N
Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203
[TBL] [Abstract][Full Text] [Related]
5. Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.
Luo L; Cai L; Luo L; Tang Z; Meng X
Mol Med Rep; 2018 Jun; 17(6):8053-8060. PubMed ID: 29693700
[TBL] [Abstract][Full Text] [Related]
6. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer.
Cai S; Fu S; Zhang W; Yuan X; Cheng Y; Fang J
Biochem Biophys Res Commun; 2021 Nov; 577():158-164. PubMed ID: 34530350
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the SLC7A11/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma.
Wang HH; Fan SQ; Zhan YT; Peng SP; Wang WY
Int J Biol Macromol; 2024 Jan; 254(Pt 3):127976. PubMed ID: 37951442
[TBL] [Abstract][Full Text] [Related]
8. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.
Ni H; Ruan G; Sun C; Yang X; Miao Z; Li J; Chen Y; Qin H; Liu Y; Zheng L; Xing Y; Xi T; Li X
Environ Toxicol; 2022 Feb; 37(2):192-200. PubMed ID: 34661962
[TBL] [Abstract][Full Text] [Related]
10. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer.
Li H; Yu Y; Liu Y; Luo Z; Law BYK; Zheng Y; Huang X; Li W
Pharmacol Res; 2022 Aug; 182():106306. PubMed ID: 35714823
[TBL] [Abstract][Full Text] [Related]
12. p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma.
Song WJ; Dong Y; Luo C; Chen YY
Pathol Res Pract; 2017 Oct; 213(10):1282-1288. PubMed ID: 28916425
[TBL] [Abstract][Full Text] [Related]
13. POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase.
Peng Y; Zheng W; Chen Y; Lei X; Yang Z; Yang Y; Liang W; Sun K; Li G; Yu J
Cell Death Dis; 2024 Apr; 15(4):248. PubMed ID: 38575587
[TBL] [Abstract][Full Text] [Related]
14. ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression.
Li Y; Yan J; Zhao Q; Zhang Y; Zhang Y
Front Pharmacol; 2022; 13():904314. PubMed ID: 36210815
[TBL] [Abstract][Full Text] [Related]
15. FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis.
Niu L; Li Y; Huang G; Huang W; Fu J; Feng L
Commun Biol; 2024 Apr; 7(1):399. PubMed ID: 38565940
[TBL] [Abstract][Full Text] [Related]
16. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis.
Li Y; Yang W; Zheng Y; Dai W; Ji J; Wu L; Cheng Z; Zhang J; Li J; Xu X; Wu J; Yang M; Feng J; Guo C
J Exp Clin Cancer Res; 2023 Jan; 42(1):6. PubMed ID: 36604718
[TBL] [Abstract][Full Text] [Related]
17. Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma.
Li X; Li Y; Lian P; Lv Q; Liu F
Hum Exp Toxicol; 2023; 42():9603271221142818. PubMed ID: 36786348
[TBL] [Abstract][Full Text] [Related]
18. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
19. ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.
Wu DS; Chen C; Wu ZJ; Liu B; Gao L; Yang Q; Chen W; Chen JM; Bao Y; Qu L; Wang LH
J Exp Clin Cancer Res; 2016 Jul; 35(1):108. PubMed ID: 27377902
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
